TSXV/RX (TSXV/RX)

TSX Venture Exchange: TSXV/RX · CAD

CA$17.0

+0.31 (+1.9%)· Recorded snapshot

Market cap	192.3M
Revenue (ttm)	55.7M
Net income (ttm)	9.9M
EPS (ttm)	CA$0.85
Shares out	11.3M
P/E (trailing)	19.9x
P/E (forward)	16.1x
Dividend	CA$0.22 (1.29%)
Volume	6,922
Beta	0.59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 55.7M
Net income (ttm): 9.9M
EPS (ttm): CA$0.85
P/E (trailing): 19.9x
P/E (forward): 16.1x
Market cap: 192.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.1

P25 n/aP50 n/aP75 n/a

Trailing P/E19.9

P25 n/aP50 n/aP75 n/a

ROE23.7

P25 n/aP50 n/aP75 n/a

ROIC24.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/RX indicators

Market & fundamental data

Available fields

259

Groups with data

Currency

CAD

Showing 259 of 259 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-17
Enterprise value	CAD 186.4M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2006
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA0906901081
Last earnings date	2026-08-20
Last refreshed	2026-10-28
Market cap	CAD 192.3M
Next earnings date	2026-11-17
Price	CAD 17.00
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsxv/RX
Website	https://www.biosyent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.53x
Average P/E ratio (3Y)	16.3x
Average P/E ratio (5Y)	16.45x
Earnings yield	5.02%
EV/Earnings	18.54x
EV/EBIT	13.84x
EV/EBITDA	12.12x
EV/FCF	15.97x
EV/Sales	3.29x
FCF / EV yield	6.26%
FCF yield	6.07%
Forward P/E	16.13x
Graham number	8.81435
Graham upside	-47.19%
Industry forward P/E	34.53x
Lynch fair value	CAD 15.42
Lynch upside	-7.61%
P/(FCF - SBC) ratio	17.52x
P/(OCF - SBC) ratio	17.45x
P/B ratio	4.12x
P/E ratio	19.9x
P/FCF ratio	16.47x
P/OCF ratio	16.41x
P/S ratio	3.39x
Price / tangible book value	9.7x
Price/EBITDA ratio	12.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	23.74%
EBITDA margin	26.73%
Effective tax rate	26.26%
FCF margin	20.58%
Gross margin	73.38%
Operating margin	23.74%
Pretax margin	24.04%
Profit margin	17.73%
Profitable quarters	61
Profitable years	16
ROA	15.9%
ROA (5Y)	13.27%
ROCE	28.33%
ROE	23.65%
ROE (5Y)	20.35%
ROIC	24.56%
ROIC (5Y)	83.4%
SBC / revenue	1.23%
Tax / revenue	6.31%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	20.37%
EPS growth (Q)	39.21%
EPS growth (QoQ)	21.29%
EPS growth 10Y	12.21%
EPS growth 3Y	25.81%
EPS growth 5Y	20.62%
EPS growth quarters	1
EPS growth years	3
FCF growth	-3.8%
FCF growth (Q)	-27.31%
FCF growth (QoQ)	-6.84%
FCF growth 3Y	28.6%
FCF growth 5Y	21.82%
Gross profit growth	32.24%
Gross profit growth (Q)	76.55%
Gross profit growth 3Y	20.01%
Gross profit growth 5Y	14.84%
Net income growth	19.48%
Net income growth (Q)	41.19%
Net income growth (QoQ)	21.52%
Net income growth 3Y	22.94%
Net income growth 5Y	18.05%
Net income growth quarters	7
Net income growth years	3
OCF growth	-3.9%
OCF growth (Q)	-27.21%
OCF growth (QoQ)	-7.16%
OCF growth 10Y	10.67%
OCF growth 3Y	28.56%
OCF growth 5Y	21.71%
Operating income growth	23.75%
Operating income growth (Q)	59.53%
Operating income growth 3Y	27.23%
Operating income growth 5Y	17.77%
Revenue growth	40.91%
Revenue growth (Q)	95.23%
Revenue growth (QoQ)	42.89%
Revenue growth 10Y	12.84%
Revenue growth 3Y	24.72%
Revenue growth 5Y	16.26%
Revenue growth quarters	13
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -45,642
Depreciation and amortization	CAD 1.7M
EBIT	CAD 13.2M
EBITDA	CAD 14.9M
EPS	CAD 0.85
FCF per share	CAD 1.01
Financing cash flow	CAD -4.2M
Free cash flow	CAD 11.5M
Free cash flow minus SBC	CAD 10.8M
Gross profit	CAD 40.9M
Income taxes	CAD 3.5M
Investing cash flow	CAD -15.6M
Net borrowing	CAD 1.7M
Net cash flow	CAD -8.3M
Net income	CAD 9.9M
Operating cash flow minus SBC	CAD 10.8M
Operating income	CAD 13.2M
Revenue	CAD 55.7M
Stock-based compensation	CAD 686,083

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	8.79
Book value per share	CAD 4.04
Debt / EBITDA	0.21
Debt / equity	0.07
Debt / FCF	0.27
Goodwill	CAD 3.8M
Interest coverage	124.01
Long-term assets	CAD 31.9M
Long-term liabilities	CAD 820,315
Net cash (debt)	CAD 5.8M
Net cash / market cap	3.07%
Net cash growth	-70.13%
Net debt / EBITDA	-0.39
Net debt / equity	-0.13
Net debt / FCF	-0.51
Piotroski F-Score	5
Property, plant and equipment	CAD 1.5M
Shareholders' equity	CAD 45.8M
Tangible book value	CAD 19.5M
Tangible book value per share	CAD 1.72
Total assets	CAD 60.5M
Total cash	CAD 8.9M
Total debt	CAD 3.1M
Total liabilities	CAD 14.6M
WACC	7.43%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.07
Current assets	CAD 28.5M
Current liabilities	CAD 13.8M
Current ratio	2.07
Inventory turnover	1.9
Net working capital	CAD 8.2M
Quick ratio	1.13
Working capital	CAD 14.7M
Working capital turnover	2.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.72%
Dividend growth	10.26%
Dividend growth (3Y)	10.35%
Dividend growth years	3
Dividend payment date	2026-09-15
Dividend payment years	5
Dividend payout frequency	Quarterly
Dividend per share	CAD 0.22
Dividend yield	1.29%
Ex-dividend date	2026-08-31
FCF payout ratio	21.71%
Last dividend	CAD 0.06
Payout ratio	24.01%
Shareholder yield	2.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	105.95%
10Y return CAGR	8.28%
10Y total return	121.46%
150-day SMA	CAD 15.07
15Y price change	5,480.65%
15Y return CAGR	31.38%
15Y total return	5,900.86%
1D price change	1.86%
1M price change	6.79%
1M total return	6.79%
1W price change	2.01%
1W total return	2.01%
1Y price change	56.42%
1Y return CAGR	58.86%
1Y total return	58.81%
20-day SMA	CAD 16.72
200-day SMA	CAD 14.86
20Y price change	13,207.69%
20Y return CAGR	28.17%
20Y total return	14,209.7%
3M price change	17.37%
3M total return	17.78%
3Y price change	118.99%
3Y return CAGR	32.08%
3Y total return	130.46%
50-day SMA	CAD 16.20
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 17.50
52-week high date	2026-09-22
52-week low	CAD 10.65
52-week low date	2025-11-20
5Y price change	154.04%
5Y return CAGR	22.26%
5Y total return	173.17%
6M price change	16.5%
6M total return	17.37%
All-time high	CAD 17.50
All-time high date	2026-09-22
All-time low	CAD 0.01
All-time low date	2001-12-13
Average true range (ATR)	CAD 0.47
Average volume	6.2K
Beta (1Y)	0.87
Beta (2Y)	0.87
Beta (5Y)	0.59
Change from 52-week high	-2.86%
Change from 52-week low	59.62%
Change from all-time high	-1.14%
Change from all-time low	172,900%
Change from open	1.19%
Day's gap	0.66%
Dollar volume	CAD 117,674
High price	CAD 17.40
Low price	CAD 16.80
Monthly RSI	75.07
Open price	CAD 16.80
Position in 52-week range	33.33%
Previous close	CAD 16.69
Price vs 150-day SMA	14.77%
Price vs 20-day SMA	3.49%
Price vs 200-day SMA	16.45%
Price vs 50-day SMA	6.82%
Relative volume	1.12
RSI	60.44
Sharpe ratio	1.46
Sharpe ratio (3Y)	0.98
Sharpe ratio (5Y)	0.61
Sortino ratio	2.78
Sortino ratio (3Y)	1.83
Sortino ratio (5Y)	1.15
Volume	6.9K
Weekly RSI	72.69
YTD price change	35.9%
YTD total return	37.41%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9.1M
Shares change (QoQ)	0.27%
Shares change (YoY)	-0.72%
Shares held by insiders	9.56%
Shares held by institutions	10.19%
Shares outstanding	11.3M

Deeper analysis on TSXV/RX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/RX report

Is a complete TSXV/RX research report available?

No complete published report is available for tsxv/RX (TSXV/RX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/RX (TSXV/RX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/RX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/RX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/RX

Frequently asked questions